Serghei Covantsev

Dr. Serghei Covantsev

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2018 in Current Cardiology Reviews
Verified
Journal Article
Closed access
PDF file
VZVladlena I. Zozina
Vladlena I. Zozina
SCSerghei Covantsev
Serghei Covantsev
OGOlga A. Goroshko
Olga A. Goroshko
LKLiudmila M. Krasnykh
Liudmila M. Krasnykh
VKVladimir G. Kukes
Vladimir G. Kukes
The burden of cardiovascular and metabolic diseases is increasing with every year. Although the management of these conditions has improved greatly over the years it is still far from perfect. With all of this in mind, there is a need for new methods of prophylaxis and treatment. Coenzyme Q10 (CoQ10) is an essential compound of the human body. There is growing evidence that CoQ10 is tightly linked to cardiometabolic disorders. Its supplementation can be useful in a variety of chronic and acute disorders. This review analyses the role of CoQ10 in hypertension, ischemic heart disease, myocardial infarction, heart failure, viral myocarditis, cardiomyopathies, cardiac toxicity, dyslipidemia, obesity, type 2 diabetes mellitus, metabolic syndrome, cardiac procedures and resuscitation.

1 November 2016 in Respiratory Investigation
Verified
Journal Article
Closed access
Alexandru CorlateanuAlexandru Corlateanu
Alexandru Corlateanu
SCSerghei Covantsev
Serghei Covantsev
Alexander MathioudakisAlexander Mathioudakis
Alexander Mathioudakis
VBVictor Botnaru
Victor Botnaru
NSNikolaos Siafakas
Nikolaos Siafakas

10 May 2018 in COPD: Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Closed access
Alexandru CorlateanuAlexandru Corlateanu
Alexandru Corlateanu
SCSerghei Covantsev
Serghei Covantsev
Alexander MathioudakisAlexander Mathioudakis
Alexander Mathioudakis
VBVictor Botnaru
Victor Botnaru
MCMario Cazzola
Mario Cazzola
NSNikolaos Siafakas
Nikolaos Siafakas
Chronic obstructive pulmonary disease (COPD) is currently the fourth leading cause of death in the world and its incidence and prevalence is on the rise. It is evident that COPD is linked to cardiovascular disease. In the last years, several studies demonstrated that COPD may also be a risk factor for stroke, another major cause of death worldwide. Taking in consideration that COPD has multiple comorbidities it is hard to say whether COPD is an independent risk factor for stroke or it is due to confounding effect. This review is aimed to discuss current data on COPD and stroke, potential links, therapy, and prevention. Current data suggest that COPD may increase the risk of hemorrhagic stroke. The incidence of other stroke subtypes may also be increased in COPD or may be due to confounding effect. However, COPD patients who have stroke are at risk for pulmonary and extrapulmonary complications. We conclude that more studies are needed to further clarify the links between COPD and stroke. The management of COPD as well as the use of prevention therapy is essential to decrease the risk for stroke and should be at special attention in pulmonary medicine and neurology.

19 June 2023 in Clocks & Sleep
Verified
Journal Article
Open access
PDF file
VSVictoria Sircu
Victoria Sircu
SCSilvia Iaroslava Colesnic
Silvia Iaroslava Colesnic
SCSerghei Covantsev
Serghei Covantsev
OCOlga Corlateanu
Olga Corlateanu
ASAnna Sukhotko
Anna Sukhotko
Alexandru CorlateanuAlexandru Corlateanu
Alexandru Corlateanu
Micro-arousals and the repeated desaturation of oxyhemoglobin, which are typical in obstructive sleep apnea syndrome (OSAS), have adverse effects on the health of patients, leading to a wide range of complications such as cardiovascular (arterial hypertension, pulmonary hypertension, chronic heart failure, arrhythmias, myocardial infarction), cerebrovascular (strokes), metabolic (insulin resistance, obesity, diabetes mellitus, metabolic syndrome), gastrointestinal (non-alcoholic liver disease), urinary (chronic renal failure), and neuropsychiatric complications as well as a wide range of malignancies. These, in turn, have multilateral effects on familial, occupational, and social life, as well as increasing the risks of road traffic accidents and accidents at the workplace. Awareness, timely screening, and the prevention of complications play important roles in diagnosing and treating comorbid conditions. This review focuses on comorbidities in OSAS and the effect of Continuous Positive Airway Pressure (CPAP) therapy on their prognoses.

1 August 2021 in Respiratory Medicine
Verified
Journal Article
Closed access
Alexandru CorlateanuAlexandru Corlateanu
Alexandru Corlateanu
APAlexandra Plahotniuc
Alexandra Plahotniuc
OCOlga Corlateanu
Olga Corlateanu
VBVictor Botnaru
Victor Botnaru
Andras BikovAndras Bikov
Andras Bikov
NSNikolaos Siafakas
Nikolaos Siafakas

1 April 2024 in Journal of Multidisciplinary Healthcare
Verified
Journal Article
Open access
PDF file
Alexandr Ceasovschih, Assist. Prof., PhDAlexandr Ceasovschih, Assist. Prof., PhD
Alexandr Ceasovschih, Assist. Prof., PhD
VSVictorita Sorodoc
Victorita Sorodoc
SCSerghei Covantsev
Serghei Covantsev
ABAnastasia Balta
Anastasia Balta
JUJamol Uzokov
Jamol Uzokov
LȘLaurențiu Șorodoc
Laurențiu Șorodoc
Despite the noteworthy advancements and the introduction of new technologies in diagnostic tools for cardiovascular disorders, the electrocardiogram (ECG) remains a reliable, easily accessible, and affordable tool to use. In addition to its crucial role in cardiac emergencies, ECG can be considered a very useful ancillary tool for the diagnosis of many non-cardiac diseases as well. In this narrative review, we aimed to explore the potential contributions of ECG for the diagnosis of non-cardiac diseases such as stroke, migraine, pancreatitis, Kounis syndrome, hypothermia, esophageal disorders, pulmonary embolism, pulmonary diseases, electrolyte disturbances, anemia, coronavirus disease 2019, different intoxications and pregnancy.